Conceptualizing multiple drug use in patients with comorbidity and multimorbidity: proposal for standard definitions beyond the term polypharmacy

This publication has 73 references indexed in Scilit:

• Metformin: an old but still the best treatment for type 2 diabetes
  Diabetology & Metabolic Syndrome, 2013
• Polypharmacy in elderly patients with cancer: clinical implications and management
  The Lancet Oncology, 2011
• Potential health impacts of multiple drug prescribing for older people: a case-control study
  British Journal of General Practice, 2011
• Drug utilization and polypharmacy in an Italian elderly population: the EPIFARM‐elderly project
  Pharmacoepidemiology and Drug Safety, 2011
• HFSA 2010 Comprehensive Heart Failure Practice Guideline
  Journal of Cardiac Failure, 2010
• Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen
  Journal of Clinical Oncology, 2010
• Drug–drug interactions – a preventable patient safety issue?
  British Journal of Clinical Pharmacology, 2007
• Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug‐related problems
  British Journal of Clinical Pharmacology, 2006
• Significant Effect of Capecitabine on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Cancer
  Journal of Clinical Oncology, 2005
• Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
  The Lancet, 2005